Source - SMW
Smith & Nephew said a trial has shown that the addition of its multi-layer polyurethane dressing significantly reduces the onset of pressure ulcers in elderly patients admitted to hospital for hip fracture.

The trial found that 15.4% of patients receiving standard care developed a pressure ulcer as opposed to only 4.5% of the group who received the same care with the addition of its Allevyn Life product.  


At 9:54am: (LON:SN.) Smith  Nephew PLC share price was -12.5p at 1326.5p



Related Charts

Smith & Nephew (SN.)

0.00 (0.00%)
delayed 17:30PM